Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency
9.2.1.2 Oral sodium and water - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
Please note, expiry dates of licensed and unlicensed oral solutions can vary greatly.
10.1.3 Drugs that suppress the rheumatic disease process - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
Near Patient Testing (NPT) arrangements for GPs may be in place for this medicine. See the relevant section in the Prescribing Resources page for current information.
4.8.1 Control of the epilepsies - View Category
Restrictions:
Restricted to specialist initiation only.
Prescribing Notes:
Prescribe by brand name.
Children exposed to valproate in utero are at high risk of developmental disorder and congenital malformations. For further information and communication materials for prescribers to use in their discussions with patients, see MHRA guidance here (latest update January 2024)
Valproate should NOT be used routinely in women of child-bearing age for the treatment of Bipolar Disorder. If it is deemed clinically necessary, then all aspects of the prevent programme MUST be followed and documented.
9.2.1.1 Oral potassium - View Category
Restrictions:
Restricted to specialist use in the emergency care setting for the treatment of acute, life-threatening hyperkalaemia alongside standard care.
9.2.1.1 Oral potassium - View Category
16.2 Specific antidotes - View Category
16.2 Specific antidotes - View Category
7.3.5 Emergency contraception - View Category
Prescribing Notes:
- Ulipristal is licensed for use in women presenting up to 120 hours after unprotected intercourse for whom the insertion of an IUD is not acceptable.
- Please follow the FSRH guidance for appropriate use.